AFFILIN
DEAD

Serial Number

76396579

Owner

Scil Proteins GmbH

Attorney

RICHARD E. JENKINS

Filing Date

Apr 16, 2002

Add to watchlist:

No watchlists yet
View on USPTO

AFFILIN Trademark

Serial Number: 76396579 • Registration: 3379852

AFFILIN is a trademark filed by Scil Proteins GmbH on April 16, 2002. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Scil Proteins GmbH (3 trademarks)

Heinrich-Damerow-Str. 1

Entity Type: 99

Trademark Details

Filing Date

April 16, 2002

Registration Date

February 12, 2008

Published for Opposition

June 7, 2005

Cancellation Date

September 19, 2014

Goods & Services

PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF CYSTIC FIBROSIS, PSYCHOSOMATIC DISEASES, DEPRESSION, EPILEPSY, ENDOCRINOLOGIC DISORDERS, CIRRHOSES, DISEASES ASSOCIATED WITH HORMONAL DISTURBANCES, AUTOIMMUNE DISEASES, EYE DISEASES, OBESITY, METABOLIC DISEASES, STROKE, INFECTIOUS DISEASES, CANCER, DEGENERATIVE DISEASES, NEURODEGENERATIVE DISEASES, ASTHMATIC DISEASES, DERMATOLOGIC DISEASES, MUSCULOSKELETAL DISEASES, PERIODONTOSIS, DENTAL DISEASES, DIABETES, CARDIOVASCULAR DISEASES, INFLAMMATORY DISEASES, HEMATOLOGIC DISEASES, UROLOGIC DISEASES OR ERECTILE DYSFUNCTIONS, PSYCHOLOGICAL DISEASES, BRONCHOLYTIC DISEASES, PULMONARY DISEASES, DERMATOLOGICAL DISEASES, LIPID METABOLISM DISORDERS, MIGRAINE, DEMENTIA, RHEUMATIC DISORDERS, GASTRIC AND INTESTINAL DISEASES, ENZYME DEFICIENCY AND TRANSPORT PROTEINS DISORDERS, ANALEPTIC DISEASES, ANORETIC DISEASES, BLOOD DISEASES, ALLERGIC DISEASES, ANEMIC DISEASES, GERIATRIC DISEASES, COLD AND FLU, HEPATIC DISEASES, IMMUNOLOGICAL DISEASES, CARDIAC DISEASES, SKELETAL AND MUSCLE DISEASES, OSTEOPOROSIS, OTOLOGICAL DISEASES, MOUTH AND PHARYNGEAL DISEASES, ASTHMATIC DISEASES, BILE-DUCT DISORDERS, AND ARTERIOSCLEROSIS; VETERINARY PREPARATIONS FOR USE IN THE TREATMENT OF CYSTIC FIBROSIS, PSYCHOSOMATIC DISEASES, DEPRESSION, EPILEPSY, ENDOCRINOLOGIC DISORDERS, CIRRHOSES, DISEASES ASSOCIATED WITH HORMONAL DISTURBANCES, AUTOIMMUNE DISEASES, EYE DISEASES, OBESITY, METABOLIC DISEASES, STROKE, INFECTIOUS DISEASES, CANCER, DEGENERATIVE DISEASES, NEURODEGENERATIVE DISEASES, ASTHMATIC DISEASES, DERMATOLOGIC DISEASES, MUSCULOSKELETAL DISEASES, PERIODONTOSIS, DENTAL DISEASES, DIABETES, CARDIOVASCULAR DISEASES, INFLAMMATORY DISEASES, HEMATOLOGIC DISEASES, UROLOGIC DISEASES OR ERECTILE DYSFUNCTIONS, PSYCHOLOGICAL DISEASES, BRONCHOLYTIC DISEASES, PULMONARY DISEASES, DERMATOLOGIC DISEASES, LIPID METABOLISM DISORDERS, MIGRAINE, DEMENTIA, RHEUMATIC DISORDERS, GASTRIC AND INTESTINAL DISEASES, ENZYME DEFICIENY AND TRANSPORT PROTEINS DISORDERS, ANALEPTIC DISEASES, ANORETIC DISEASES, BLOOD DISEASES, ALLERGIC DISEASES, ANEMIC DISEASES, GERIATRIC DISEASES, COLD AND FLU, HEPATIC DISEASES, IMMUNOLOGICAL DISEASES, CARDIAC DISEASES, SKELETAL AND MUSCLE DISEASES, OSTEOPOROSIS, OTOLOGICAL DISEASES, MOUTH AND PHARYNGEAL DISEASES, ASTHMATIC DISEASES, BILE-DUCT DISORDERS, AND ARTERIOSCLEROSIS; MEDICAL, DIAGNOSTIC, CHEMICAL AND ANALYTIC REAGENTS FOR USE IN THE TREATMENT OF CYSTIC FIBROSIS, PSYCHOSOMATIC DISEASES, DEPRESSION, EPILEPSY, ENDOCRINOLOGIC DISORDERS, CIRRHOSES, DISEASES ASSOCIATED WITH HORMONAL DISTURBANCES, AUTOIMMUNE DISEASES, EYE DISEASES, OBESITY, METABOLIC DISEASES, STROKE, INFECTIOUS DISEASES, CANCER, DEGENERATIVE DISEASES, NEURODEGENERATIVE DISEASES, ASTHMATIC DISEASES, DERMATOLOGIC DISEASES, MUSCULOSKELETAL DISEASES, PERIODONTOSIS, DENTAL DISEASES, DIABETES, CARDIOVASCULAR DISEASES, INFLAMMATORY DISEASES, HEMATOLOGIC DISEASES, UROLOGIC DISEASES OR ERECTILE DYSFUNCTIONS, PSYCHOLOGICAL DISEASES, BRONCHOLYTIC DISEASES, PULMONARY DISEASES, DERMATOLOGIC DISEASES, LIPID METABOLISM DISORDERS, MIGRAINE, DEMENTIA, RHEUMATIC DISORDERS, GASTRIC AND INTESTINAL DISEASES, ENZYME DEFICIENCY AND TRANSPORT PROTEINS DISORDERS, ANALEPTIC DISEASES, ANORETIC DISEASES, BLOOD DISEASES, ALLERGIC DISEASES, ANEMIC DISEASES, GERIATRIC DISEASES, COLD AND FLU, HEPATIC DISEASES, IMMUNOLOGICAL DISEASES, CARDIAC DISEASES, SKELETAL AND MUSCLE DISEASES, OSTEOPOROSIS, OTOLOGICAL DISEASES, MOUTH AND PHARYNGEAL DISEASES, ASTHMATIC DISEASES, BILE-DUCT DISORDERS, AND ARTERIOSCLEROSIS; AND DIAGNOSTIC PREPARATIONS FOR CLINICAL AND MEDICAL LABORATORY USE

chemical preparations, namely, artificial binding molecules in the nature of proteins and peptides for use in the environmental industry, biotechnological industry, food industry, cosmetic industry, and gmp production; chemical substances, namely biologically active proteins and peptides with antibody-like binding activities for use in the environmental industry, biotechnological industry, food industry, cosmetic industry, and gmp production; diagnostic reagents and analytical reagents for scientific research use or for use in the biotechnological industry, pharmaceutical industry, food industry, cosmetic industry, and gmp production or for laboratory use or for purification or depletion of chemical or biological substances

Filing History

CANCELLED SEC. 8 (6-YR)
Sep 19, 2014 C8..
REGISTERED-PRINCIPAL REGISTER
Feb 12, 2008 R.PR
OPPOSITION TERMINATED NO. 999999
Jan 9, 2008 OP.T
OPPOSITION DISMISSED NO. 999999
Jan 8, 2008 OP.D
ASSIGNED TO EXAMINER
Jun 5, 2007 DOCK
OPPOSITION INSTITUTED NO. 999999
Dec 5, 2005 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
Jun 30, 2005 ETOF
PUBLISHED FOR OPPOSITION
Jun 7, 2005 PUBO
NOTICE OF PUBLICATION
May 18, 2005 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 16, 2005 PREV
ASSIGNED TO LIE
Feb 11, 2005 ALIE
ASSIGNED TO LIE
Jan 24, 2005 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 21, 2004 CNSA
FINAL REFUSAL MAILED
Jul 19, 2004 CNFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 14, 2004 CRFA
PAPER RECEIVED
May 14, 2004 MAIL
INQUIRY AS TO SUSPENSION MAILED
Nov 13, 2003 CNSI
CASE FILE IN TICRS
Oct 23, 2003 CFIT
LETTER OF SUSPENSION MAILED
Apr 2, 2003 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 19, 2003 CRFA
PAPER RECEIVED
Feb 19, 2003 MAIL
NON-FINAL ACTION MAILED
Aug 26, 2002 CNRT
ASSIGNED TO EXAMINER
Aug 8, 2002 DOCK